Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials

OBJECTIVES: Typically, prognostic capability of gene expression profiling (GEP) is studied in the context of clinical trials, for which 50%‐80% of patients are not eligible, possibly limiting the generalizability of findings to routine practice. Here, we evaluate GEP analysis outside clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan‐Ting, Valent, Erik T., van Beers, Erik H., Kuiper, Rowan, Oliva, Stefania, Haferlach, Torsten, Chng, Wee‐Joo, van Vliet, Martin H., Sonneveld, Pieter, Larocca, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290833/
https://www.ncbi.nlm.nih.gov/pubmed/34448362
http://dx.doi.org/10.1111/ijlh.13691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290833/
https://www.ncbi.nlm.nih.gov/pubmed/34448362
http://dx.doi.org/10.1111/ijlh.13691

Ejemplares similares